As per corporate shareholdings filed for Feb-2025, people matching Candriam Global Equities Oncology publicly holds 52 stocks with a net worth of over US$ 1.1 B.
These are shares held by Candriam Global Equities Oncology as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
---|---|---|---|---|---|---|---|---|
Mirati Therapeutics Inc | Candriam Global Equities Oncology | 58.70 | 499,720 | 0.71% | 0.00 | 29.3 M | ||
Seagen Inc | Candriam Global Equities Oncology | 228.88 | 256,015 | 0.14% | 0.00 | 58.6 M | ||
Immunogen, Inc. | Candriam Global Equities Oncology | 31.23 | 782,876 | 0.28% | 0.00 | 24.4 M | ||
Agilent Technologies Inc. | Candriam Global Equities Oncology | 106.28 | 95,160 | 0.03% | 0.00 | 10.1 M | ||
Arcellx Inc | Candriam Global Equities Oncology | 63.71 | 118,272 | 0.22% | 0.00 | 7.5 M | ||
AMGEN Inc. | Candriam Global Equities Oncology | 280.84 | 281,499 | 0.05% | 0.00 | 79.1 M | ||
Arvinas Inc | Candriam Global Equities Oncology | 9.05 | 408,030 | 0.59% | 0.00 | 3.7 M | ||
Bicycle Therapeutics Plc - ADR | Candriam Global Equities Oncology | 8.42 | 492,114 | 0.71% | 0.00 | 4.1 M | ||
Bristol-Myers Squibb Co. | Candriam Global Equities Oncology | 47.90 | 470,289 | 0.02% | 0.00 | 22.5 M | ||
BioNTech SE - ADR | Candriam Global Equities Oncology | 102.02 | 388,595 | 0.16% | 0.00 | 39.6 M | ||
Day One Biopharmaceuticals Inc | Candriam Global Equities Oncology | 7.74 | 290,000 | 0.29% | 0.00 | 2.2 M | ||
Danaher Corp. | Candriam Global Equities Oncology | 197.14 | 133,878 | 0.02% | 0.00 | 26.4 M | ||
Exact Sciences Corp. | Candriam Global Equities Oncology | 45.46 | 443,771 | 0.24% | 0.00 | 20.2 M | ||
Guardant Health Inc | Candriam Global Equities Oncology | 48.30 | 366,123 | 0.30% | 0.00 | 17.7 M | ||
Gilead Sciences, Inc. | Candriam Global Equities Oncology | 103.17 | 888,000 | 0.07% | 0.00 | 91.6 M | ||
Hologic, Inc. | Candriam Global Equities Oncology | 58.02 | 923,470 | 0.41% | 0.00 | 53.6 M | ||
Icon Plc | Candriam Global Equities Oncology | 144.96 | 124,298 | 0.15% | 0.00 | 18.0 M | ||
Ideaya Biosciences Inc | Candriam Global Equities Oncology | 19.00 | 498,000 | 0.57% | 0.00 | 9.5 M | ||
Illumina Inc | Candriam Global Equities Oncology | 77.35 | 109,110 | 0.07% | 0.00 | 8.4 M | ||
Immunocore Holdings plc - ADR | Candriam Global Equities Oncology | 30.16 | 140,000 | 0.28% | 0.00 | 4.2 M | ||
Immatics N.V | Candriam Global Equities Oncology | 4.52 | 678,380 | 0.56% | 0.00 | 3.1 M | ||
Incyte Corp. | Candriam Global Equities Oncology | 59.16 | 427,120 | 0.22% | 0.00 | 25.3 M | ||
Iovance Biotherapeutics Inc | Candriam Global Equities Oncology | 3.51 | 500,000 | 0.15% | 0.00 | 1.8 M | ||
IQVIA Holdings Inc | Candriam Global Equities Oncology | 150.28 | 203,883 | 0.12% | 0.00 | 30.6 M | ||
Intuitive Surgical Inc | Candriam Global Equities Oncology | 514.59 | 22,776 | 0.01% | 0.00 | 11.7 M | ||
ITeos Therapeutics Inc | Candriam Global Equities Oncology | 7.35 | 233,618 | 0.61% | 0.00 | 1.7 M | ||
Janux Therapeutics Inc | Candriam Global Equities Oncology | 31.05 | 137,096 | 0.23% | 0.00 | 4.3 M | ||
Keros Therapeutics Inc | Candriam Global Equities Oncology | 14.21 | 183,576 | 0.45% | 0.00 | 2.6 M | ||
Kura Oncology Inc | Candriam Global Equities Oncology | 6.43 | 438,996 | 0.54% | 0.00 | 2.8 M | ||
Kymera Therapeutics Inc | Candriam Global Equities Oncology | 33.26 | 95,815 | 0.15% | 0.00 | 3.2 M | ||
Legend Biotech Corp - ADR | Candriam Global Equities Oncology | 34.28 | 230,411 | 0.13% | 0.00 | 7.9 M | ||
Lilly(Eli) & Co | Candriam Global Equities Oncology | 884.54 | 124,921 | 0.01% | 0.00 | 110.5 M | ||
Lantheus Holdings Inc | Candriam Global Equities Oncology | 101.77 | 118,000 | 0.17% | 0.00 | 12.0 M | ||
Medpace Holdings Inc | Candriam Global Equities Oncology | 298.55 | 52,698 | 0.18% | 0.00 | 15.7 M | ||
Merck & Co Inc | Candriam Global Equities Oncology | 82.74 | 881,504 | 0.04% | 0.00 | 72.9 M | ||
Moderna Inc | Candriam Global Equities Oncology | 27.22 | 219,588 | 0.06% | 0.00 | 6.0 M | ||
Merus N.V | Candriam Global Equities Oncology | 43.57 | 360,421 | 0.52% | 0.00 | 15.7 M | ||
Neogenomics Inc. | Candriam Global Equities Oncology | 10.27 | 467,000 | 0.36% | 0.00 | 4.8 M | ||
Nurix Therapeutics Inc | Candriam Global Equities Oncology | 11.56 | 624,817 | 0.82% | 0.00 | 7.2 M | ||
Natera Inc | Candriam Global Equities Oncology | 153.79 | 216,603 | 0.16% | 0.00 | 33.3 M | ||
Nuvalent Inc - Ordinary Shares - Class A | Candriam Global Equities Oncology | 73.48 | 150,002 | 0.21% | 0.00 | 11.0 M | ||
Olema Pharmaceuticals Inc | Candriam Global Equities Oncology | 4.91 | 860,554 | 1.26% | 0.00 | 4.2 M | ||
Qiagen NV | Candriam Global Equities Oncology | 42.07 | 167,000 | 0.08% | 0.00 | 7.0 M | ||
Regeneron Pharmaceuticals, Inc. | Candriam Global Equities Oncology | 602.64 | 89,393 | 0.08% | 0.00 | 53.9 M | ||
Relay Therapeutics Inc | Candriam Global Equities Oncology | 3.20 | 1,092,644 | 0.64% | 0.00 | 3.5 M | ||
Revolution Medicines Inc | Candriam Global Equities Oncology | 38.77 | 346,302 | 0.19% | 0.00 | 13.4 M | ||
Summit Therapeutics Inc | Candriam Global Equities Oncology | 23.46 | 210,557 | 0.03% | 0.00 | 4.9 M | ||
Syndax Pharmaceuticals Inc | Candriam Global Equities Oncology | 13.33 | 513,513 | 0.59% | 0.00 | 6.8 M | ||
SpringWorks Therapeutics Inc | Candriam Global Equities Oncology | 44.72 | 476,721 | 0.64% | 0.00 | 21.3 M | ||
Thermo Fisher Scientific Inc. | Candriam Global Equities Oncology | 424.24 | 109,082 | 0.03% | 0.00 | 46.3 M | ||
Veracyte Inc | Candriam Global Equities Oncology | 32.23 | 231,663 | 0.30% | 0.00 | 7.5 M | ||
Zai Lab Limited - ADR | Candriam Global Equities Oncology | 32.00 | 390,000 | 0.36% | 0.00 | 12.5 M |